LUSUTROMBOPAG
| Brand name | MULPLETA |
|---|---|
| Active ingredient | LUSUTROMBOPAG |
| Strength | 3MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2018 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9427402 | September 2031 | product |
| 8530668 | January 2030 | substance, product |
| 8889722 | July 2028 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.